Outcome assessment criteria and terminology should be consistent and reported clearly

Biomed Pharmacother. 2021 Jan:133:111009. doi: 10.1016/j.biopha.2020.111009. Epub 2020 Nov 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Breast
  • Breast Neoplasms*
  • Humans
  • Proteomics
  • Trastuzumab

Substances

  • Biomarkers
  • Trastuzumab